Dr. Leslie Lehmann
Committee Member [linebreak] Clinical Director [linebreak] Pediatric Hematopoietic Stem Cell Transplant [linebreak] Dana-Farber Cancer Institute [linebreak] Boston Children's Hospital [linebreak] United States
Pediatric Hematopoietic Stem Cell Transplant
Dana-Farber Cancer Institute
Boston Children's Hospital
United States
13:35 - 13:55
Saturday 26 October, Track 1
Challenges in Myeliod Malignancies
Role of Germline Mutation Profiling in the Selection of Donors for Allogenic BMT
